4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-24-000783
Director sold 13,000 shares at an average $63.76 ($828,915)
- Director acquired 13,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lukatch Heath Director | 2024-01-02 | Option exercise 10b5-1 | +13,000 | $16.00 | $208,000 | 18,625 | D |
| Lukatch Heath Director | 2024-01-02 | Sale 10b5-1 | −1,101 | $62.85 | $69,201 | 17,524 | D |
| Lukatch Heath Director | 2024-01-02 | Sale 10b5-1 | −7,444 | $63.55 | $473,081 | 10,080 | D |
| Lukatch Heath Director | 2024-01-02 | Sale 10b5-1 | −4,164 | $64.28 | $267,662 | 5,916 | D |
| Lukatch Heath Director | 2024-01-02 | Sale 10b5-1 | −291 | $65.19 | $18,971 | 5,625 | D |
| Derivatives | |||||||
| Lukatch Heath Director | 2024-01-02 | Option exercise · Stock Option (right to buy) 10b5-1 | −13,000 | 15,000 | D | ||
| Open-market sales · 13,000 sh · avg $63.76 · $828,915 | |||||||
Loading xslF345X05/doc4.xml…